Ensysce Biosciences Financials
| ENSC Stock | USD 3.45 0.11 3.09% |
Ensysce |
Understanding current and past Ensysce Biosciences Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Ensysce Biosciences' financial statements are interrelated, with each one affecting the others. For example, an increase in Ensysce Biosciences' assets may result in an increase in income on the income statement.
Please note, the presentation of Ensysce Biosciences' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Ensysce Biosciences' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Ensysce Biosciences' management manipulating its earnings.
Ensysce Biosciences Stock Summary
Ensysce Biosciences competes with Zura Bio, Phio Pharmaceuticals, Sonnet Biotherapeutics, 180 Life, and Cardio Diagnostics. Ensysce Biosciences, Inc., a clinical-stage pharmaceutical company, engages in developing various prescription drugs for severe pain relief in opioid addiction, misuse, abuse, and overdose in the United States. It is also developing PF329, an extended-release prodrug of hydromorphone that is similar to PF614 PF8001 and PF8026 are extended and immediate-release prodrugs of amphetamine for ADHD medication abuse and PF26810, an extended-release prodrug of methadone for opioid use disorder. Ensysce Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 6 people.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | US2936021086 |
| CUSIP | 52539T107 293602108 293602405 293602207 293602504 |
| Location | California; U.S.A |
| Business Address | 7946 Ivanhoe Avenue, |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.ensysce.com |
| Phone | 858 263 4196 |
| Currency | USD - US Dollar |
Ensysce Biosciences Key Financial Ratios
| Return On Equity | -5.85 | ||||
| Return On Asset | -1.01 | ||||
| Target Price | 26.23 | ||||
| Beta | 0.65 |
Ensysce Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Ensysce Biosciences's current stock value. Our valuation model uses many indicators to compare Ensysce Biosciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Ensysce Biosciences competition to find correlations between indicators driving Ensysce Biosciences's intrinsic value. More Info.Ensysce Biosciences is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Ensysce Biosciences' earnings, one of the primary drivers of an investment's value.Ensysce Biosciences Systematic Risk
Ensysce Biosciences' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Ensysce Biosciences volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was five with a total number of output elements of fifty-six. The Beta measures systematic risk based on how returns on Ensysce Biosciences correlated with the market. If Beta is less than 0 Ensysce Biosciences generally moves in the opposite direction as compared to the market. If Ensysce Biosciences Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Ensysce Biosciences is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Ensysce Biosciences is generally in the same direction as the market. If Beta > 1 Ensysce Biosciences moves generally in the same direction as, but more than the movement of the benchmark.
About Ensysce Biosciences Financials
What exactly are Ensysce Biosciences Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Ensysce Biosciences' income statement, its balance sheet, and the statement of cash flows. Potential Ensysce Biosciences investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Ensysce Biosciences investors may use each financial statement separately, they are all related. The changes in Ensysce Biosciences's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Ensysce Biosciences's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Ensysce Biosciences March 22, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Ensysce Biosciences help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Ensysce Biosciences. We use our internally-developed statistical techniques to arrive at the intrinsic value of Ensysce Biosciences based on widely used predictive technical indicators. In general, we focus on analyzing Ensysce Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Ensysce Biosciences's daily price indicators and compare them against related drivers.
| Information Ratio | (0.23) | |||
| Maximum Drawdown | 35.3 | |||
| Value At Risk | (6.21) | |||
| Potential Upside | 9.57 |
Complementary Tools for Ensysce Stock analysis
When running Ensysce Biosciences' price analysis, check to measure Ensysce Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ensysce Biosciences is operating at the current time. Most of Ensysce Biosciences' value examination focuses on studying past and present price action to predict the probability of Ensysce Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ensysce Biosciences' price. Additionally, you may evaluate how the addition of Ensysce Biosciences to your portfolios can decrease your overall portfolio volatility.
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |